Updates and future directions regarding hand hygiene in the healthcare setting: insights from the 3rd ICPIC alcohol-based handrub (ABHR) task force.

Alcohol-based handrub Antimicrobial resistance Hand hygiene Healthcare-associated infections Infection prevention and control Microbial load Skin microbiome Technique Volume

Journal

Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411

Informations de publication

Date de publication:
29 Feb 2024
Historique:
received: 22 12 2023
accepted: 28 01 2024
medline: 4 3 2024
pubmed: 1 3 2024
entrez: 29 2 2024
Statut: epublish

Résumé

Healthcare-associated infections (HAIs) and antimicrobial resistance (AMR) pose threats to global health. Effective hand hygiene is essential for preventing HAIs and the spread of AMR in healthcare. We aimed to highlight the recent progress and future directions in hand hygiene and alcohol-based handrub (ABHR) use in the healthcare setting. In September 2023, 42 experts in infection prevention and control (IPC) convened at the 3rd International Conference on Prevention and Infection Control (ICPIC) ABHR Taskforce in Geneva, Switzerland. The purpose of this meeting was to provide a synthesis of recent evidence and formulate a research agenda on four critical areas for the implementation of effective hand hygiene practices: (1) ABHR formulations and hand rubbing techniques, (2) low-resource settings and local production of ABHR, (3) hand hygiene monitoring and technological innovations, and (4) hand hygiene standards and guidelines.

Identifiants

pubmed: 38424571
doi: 10.1186/s13756-024-01374-9
pii: 10.1186/s13756-024-01374-9
pmc: PMC10905912
doi:

Substances chimiques

Ethanol 3K9958V90M

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

26

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Investigateurs

Aeschbach Rodin (A)
Kumashita Yuichi (K)
Alléard Benjamin (A)
Lee Pamela (L)
Lu Tingxu (L)
Arbogast Jim (A)
Mermel Leonard (M)
Azzouz Chedly (A)
Barrett Emma (B)
Park Ben (P)
Quan Lelyn (Q)
Bühler Martina (B)
Capilna Andreea (C)
Serna Jiménez César (SJ)
Damani Nizam (D)
Eggerstedt Sven (E)
Teska Peter (T)
van Hall Nicole (VH)
Hansen Sonja (H)
Vos Margreet (V)
Hennig Thomas (H)
Widmer Andreas (W)
Herwaldt Loreen (H)
Yakata Kazuko (Y)
Yokoe Deborah (Y)
Bell Mike (B)
Bertho Jean Noel (BJ)
Borzykowski Tcheun-How (B)
Conly John (C)
Da Silva Carlos (DS)
Yakata Kazuko (Y)
Geva Ariel (G)
Haidegger Tamas (H)
Herwaldt Loreen (H)
Holland Carolyn (H)
Okeke Bonnie (O)
Ormandy Kevin (O)
Parneix Pierre (P)
Peters Alexandra (P)
Pouget Vanessa (P)
Robert Lionel (R)
Serna Jimenez Cesar (SJ)
Zingg Walter (Z)

Informations de copyright

© 2024. The Author(s).

Références

Antimicrob Resist Infect Control. 2022 Jan 24;11(1):16
pubmed: 35073993
J Hosp Infect. 2007 Jun;66(2):167-73
pubmed: 17513011
Am J Infect Control. 2015 Feb;43(2):162-4
pubmed: 25637117
Clin Infect Dis. 2019 Aug 1;69(4):614-620
pubmed: 30395180
Infect Control Hosp Epidemiol. 2002 Dec;23(12 Suppl):S3-40
pubmed: 12515399
Infect Control Hosp Epidemiol. 2016 Feb;37(2):219-21
pubmed: 26598073
J Hosp Infect. 2022 May;123:135-136
pubmed: 35218797
Am J Infect Control. 2016 Oct 1;44(10):1168-1171
pubmed: 27291818
Clin Infect Dis. 2021 Dec 6;73(11):e4329-e4335
pubmed: 33009907
Am J Infect Control. 2019 Mar;47(3):313-322
pubmed: 30322815
Infect Control Hosp Epidemiol. 2017 May;38(5):547-552
pubmed: 28264743
Crit Care. 2007;11(3):R52
pubmed: 17477858
PLoS One. 2014 Sep 02;9(9):e105866
pubmed: 25180508
Am J Infect Control. 2019 Mar;47(3):334-336
pubmed: 30471974
Am J Infect Control. 2020 May;48(5):503-506
pubmed: 31924389
Infect Control Hosp Epidemiol. 2015 Dec;36(12):1444-50
pubmed: 26383964
Antimicrob Resist Infect Control. 2018 May 16;7:65
pubmed: 29796251
Emerg Infect Dis. 2020 Jul;26(7):1592-1595
pubmed: 32284092
J Hosp Infect. 2018 Apr;98(4):359-364
pubmed: 28974469
J Hosp Infect. 2007 Sep;67(1):9-21
pubmed: 17719685
Infect Control Hosp Epidemiol. 2017 Mar;38(3):348-352
pubmed: 27989240
J Hosp Infect. 2022 May;123:112-118
pubmed: 35124144
Am J Infect Control. 2018 Sep;46(9):1032-1035
pubmed: 29655670
Infect Control Hosp Epidemiol. 2017 May;38(5):553-558
pubmed: 28222829
JAMA Intern Med. 2016 May 1;176(5):705-6
pubmed: 26974592
Epidemiol Infect. 2020 Sep 29;148:e229
pubmed: 32988431
Am J Infect Control. 2012 Aug;40(6):521-5
pubmed: 22264743
J Infect Prev. 2020 Jul;21(4):136-143
pubmed: 32655694
Infect Control Hosp Epidemiol. 2017 Feb;38(2):230-233
pubmed: 27817763
J Hosp Infect. 2023 Aug;138:81-84
pubmed: 37210037
J Hosp Infect. 2020 Oct;106(2):311-317
pubmed: 32763330
J Hosp Infect. 2019 Apr;101(4):383-392
pubmed: 30237118
BMC Infect Dis. 2014 Sep 20;14:511
pubmed: 25238976
Infect Dis Clin North Am. 2021 Sep;35(3):553-573
pubmed: 34362534
J Dermatol Sci. 2015 Oct;80(1):3-12
pubmed: 26278471
J Hosp Infect. 2007 Dec;67(4):336-43
pubmed: 18022285
Am J Infect Control. 2021 Jun;49(6):740-745
pubmed: 33352252
Infect Control Hosp Epidemiol. 2015 Apr;36(4):482-3
pubmed: 25782907
Am J Infect Control. 2022 Oct;50(10):1079-1090
pubmed: 35167898
Infect Control Hosp Epidemiol. 2016 Jun;37(6):661-6
pubmed: 27050843
Am J Infect Control. 2020 Sep;48(9):1062-1067
pubmed: 32565272
Am J Infect Control. 2017 Sep 1;45(9):959-963
pubmed: 28863811
Infect Control Hosp Epidemiol. 2015 Aug;36(8):957-62
pubmed: 25903555
J Hosp Infect. 2010 Aug;75(4):269-72
pubmed: 20434796
Am J Infect Control. 2019 Jun;47S:A46-A52
pubmed: 31146850
Infect Control Hosp Epidemiol. 2004 Mar;25(3):207-9
pubmed: 15061411
Infect Control Hosp Epidemiol. 2023 Mar;44(3):355-376
pubmed: 36751708
J Hosp Infect. 2021 Nov;117:17-22
pubmed: 34419521
Am J Infect Control. 2014 May;42(5):559-61
pubmed: 24655900
Infect Control Hosp Epidemiol. 2019 Nov;40(11):1248-1252
pubmed: 31533869
Bull World Health Organ. 2013 Dec 1;91(12):963-9
pubmed: 24347736
Infect Control Hosp Epidemiol. 2020 Feb;41(2):239-240
pubmed: 31826786
Lancet. 2000 Oct 14;356(9238):1307-12
pubmed: 11073019
Infect Control Hosp Epidemiol. 2017 Dec;38(12):1430-1434
pubmed: 29081301
Am J Infect Control. 2021 Mar;49(3):401-402
pubmed: 32818578
Antimicrob Resist Infect Control. 2022 Jul 6;11(1):93
pubmed: 35794648
J Hosp Infect. 2023 Mar;133:73-80
pubmed: 36646137
Infect Control Hosp Epidemiol. 2017 May;38(5):595-597
pubmed: 28052790
J Hosp Infect. 2020 Apr;104(4):419-424
pubmed: 31513881
Lancet Infect Dis. 2021 Aug;21(8):e209-e221
pubmed: 34331890

Auteurs

Ermira Tartari (E)

Faculty of Health Sciences, University of Malta, Msida, Malta.
Infection Prevention and Control Technical and Clinical Hub, Department of Integrated Health Services, World Health Organization (WHO), Geneva, Switzerland.

Fernando Bellissimo-Rodrigues (F)

Social Medicine Department. Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Daniela Pires (D)

National Institute of Health and Care Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK.

Carolina Fankhauser (C)

Clean Hospitals, Geneva, Switzerland.

Nasim Lotfinejad (N)

Infection Control Program and WHO Collaborating Centre, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.

Hiroki Saito (H)

Department of Emergency and Critical Care Medicine. Faculty of Medicine, Institute of Global Health, . Mariana University Yokohama Seibu Hospital, University of Geneva, Geneva, Switzerland.

Miranda Suchomel (M)

Institute of Hygiene and Applied Immunology, Medical University of Vienna, Vienna, Austria.

Axel Kramer (A)

Institute of Hygiene and Environmental Medicine, University Medicine Greifswald, Greifswald, Germany.

Benedetta Allegranzi (B)

Infection Prevention and Control Technical and Clinical Hub, Department of Integrated Health Services, World Health Organization (WHO), Geneva, Switzerland.

John Boyce (J)

J.M. Boyce Consulting, LLC, Hyde Park, NY, USA.

Hugo Sax (H)

Infection Prevention and Control Technical and Clinical Hub, Department of Integrated Health Services, World Health Organization (WHO), Geneva, Switzerland.
Department of Infectious Diseases, Bern University Hospital and University of Bern, Bern, Switzerland.

Andrew J Stewardson (AJ)

Department of Infectious Diseases, Central Clinical School, The Alfred Hospital, Monash University, Melbourne, Australia.

Didier Pittet (D)

Clean Hospitals, Geneva, Switzerland. didier.pittet@hcuge.ch.
Faculty of Medicine & Clean Hospitals, University of Geneva, Geneva, Switzerland. didier.pittet@hcuge.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH